2seventy bio, Inc. - Common Stock
2seventy bio, Inc. - Common Stock
Share · US9013841070 · TSVT (XNAS)
Overview Financial Indicators
5,00 USD
0,20 % 0,010 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
12.05.2025 19:59

Current Prices from 2seventy bio, Inc. - Common Stock

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
TSVT
USD
12.05.2025 19:59
5,00 USD
5,00 USD

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 0,00 % 0,00 % 79,86 % 41,64 % 21,07 % -63,69 %

Company Profile for 2seventy bio, Inc. - Common Stock Share

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.

Company Data

Name 2seventy bio, Inc. - Common Stock
Company 2seventy bio, Inc.
Symbol TSVT
Website https://www.2seventybio.com
Primary Exchange XNAS NASDAQ
ISIN US9013841070
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. William D. Baird III, M.B.A.
Market Capitalization 261 Mio
Country United States of America
Currency USD
Employees 0,1 T
Address 60 Binney Street, 02142 Cambridge
IPO Date 2021-11-03

ID Changes

Date From To
05.11.2021 TSVTV TSVT

Ticker Symbols

Name Symbol
NASDAQ TSVT

More Shares

Investors who 2seventy bio, Inc. - Common Stock hold also have the following shares in their portfolio:
BARCLAYS BANK PLC SECS 08/12/26
BARCLAYS BANK PLC SECS 08/12/26 Bond
STOCKMANN OYJ UND. FLR
STOCKMANN OYJ UND. FLR Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025